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Abstract
Inflammatory bowel disease (IBD) is associated with anaemia and oral iron replacement to
correct this can be problematic, intensifying inflammation and tissue damage. The intestinal
microbiota also plays a key role in the pathogenesis of IBD, and iron supplementation likely
influences gut bacterial diversity in patients with IBD. Here, we assessed the impact of die-
tary iron, using chow diets containing either 100, 200 or 400 ppm, fed ad libitum to adult
female C57BL/6 mice in the presence or absence of colitis induced using dextran sulfate
sodium (DSS), on (i) clinical and histological severity of acute DSS-induced colitis, and (ii)
faecal microbial diversity, as assessed by sequencing the V4 region of 16S rRNA. Increas-
ing or decreasing dietary iron concentration from the standard 200 ppm exacerbated both
clinical and histological severity of DSS-induced colitis. DSS-treated mice provided only half
the standard levels of iron ad libitum (i.e. chow containing 100 ppm iron) lost more body
weight than those receiving double the amount of standard iron (i.e. 400 ppm); p<0.01. Fae-
cal calprotectin levels were significantly increased in the presence of colitis in those consum-
ing 100 ppm iron at day 8 (5.94-fold) versus day-10 group (4.14-fold) (p<0.05), and for the
400 ppm day-8 group (8.17-fold) versus day-10 group (4.44-fold) (p<0.001). In the presence
of colitis, dietary iron at 400 ppm resulted in a significant reduction in faecal abundance of
Firmicutes and Bacteroidetes, and increase of Proteobacteria, changes which were not
observed with lower dietary intake of iron at 100 ppm. Overall, altering dietary iron intake
exacerbated DSS-induced colitis; increasing the iron content of the diet also led to changes
in intestinal bacteria diversity and composition after colitis was induced with DSS.
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Introduction
Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointes-
tinal tract. Inflammation is associated with intestinal ulceration in both ulcerative colitis (UC)
and Crohn’s disease (CD). Bleeding and malabsorption may also occur in IBD [1, 2], and iron
deficiency anaemia occurs in one-third of patients [1, 3]. The best way to administer iron
replacement to patients with IBD is a subject of debate, with both oral iron and intravenous
(IV) iron supplements being considered effective [4, 5]. However, ferrous forms of oral iron
replacement appear to be poorly absorbed, and the resultant free luminal iron likely results in
enhanced catalytic activity and production of reactive oxygen species within the intestine [6,
7]. High dose oral iron consumption appears to be associated with more side effects than half
of the standard dose of iron [8], perhaps as a result of unabsorbed iron reaching the colon.
Intravenous (IV) iron therapy offers effective alternative management of iron deficiency anae-
mia. While the route of administration is not thought to influence disease activity; oral iron
supplements have been shown to disturb the microbiota, with disturbances in bacterial phylo-
types and associated aberrations in faecal metabolites compared with IV treatment [9, 10].
The gut microbiota typically comprises greater than 1011 microorganisms per gram of intes-
tinal content [11], playing an important role in the maintenance of gut health, including pro-
tection against pathogens (colonisation resistance) and the synthesis of beneficial short-chain
fatty acids (SCFA) generated through fermentation of dietary fibre [12, 13]. IBD is associated
with a perturbation of gut microbiota (‘dysbiosis’), with the observed reduction in microbial
diversity, including a decline in beneficial bacteria from the phyla Bacteroidetes and Firmicutes,
although within these classifications a much more complicated picture exists, alongside
enhancement of some potentially harmful Proteobacteria, particularly within the family Enter-
obacteriaceae [14, 15]. The key mechanisms responsible for the development of this dysbiosis
and its contribution to IBD are to date poorly defined.
Iron is an essential metal that is required by most organisms [16]. It is a growth-limiting
nutrient for many gut bacteria, which compete for unabsorbed dietary iron in the colon [17].
Lactobacilli, considered to be beneficial intestinal barrier-maintaining bacteria, playing a sig-
nificant role in the inhibition of mucosal colonisation by enteric pathogens, do not require
iron [18]. For other bacteria, acquisition of nutrient iron is an essential step for expression of
key virulence factors, including Gram-negative enteric pathogens within the family Enterobac-
teriaceae, such as Salmonella spp., Shigella spp. and Escherichia coli pathovars [19]. Conse-
quently, an increase in unabsorbed dietary iron could favour the growth of opportunistic
pathogens over mucosal barrier-maintaining species and alter the composition of the intestinal
microbiota [20]. In the context of IBD, excess colonic iron concentrations can occur as a result
of ulceration and bleeding, as well as excess unabsorbed iron from oral iron replacement ther-
apy [21].
Iron supplementation, either oral or delivered intravenously, has been shown to have an
impact on the intestinal microbiota and metabolome of patients with IBD [10]. Comparison of
oral versus intravenous routes of iron supplementation demonstrated no significant effects on
the human bacterial diversity, although specific species changes were noted. Four Operational
Taxonomic Units (OTUs) were observed to be less abundant after oral iron therapy, including
Faecalibacterium prausnitzii, low abundance of which, has been linked to relapse in Crohn’s
disease [10]. An OTU of the Bifidobacterium genus was noted to be increased with oral iron
therapy but, the effect of prebiotics and probiotics was a confounder in 4/6 patients studied.
Overall, this study suggested that oral iron therapy might have an adverse effect on the micro-
biome; however, the contemporaneous effect of IBD was not studied.
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Murine models of IBD offer the opportunity to investigate the gut microbiota and microbial
diversity changes that occur during IBD pathogenesis [22, 23]. We hypothesised that changing
the amount of dietary iron would influence IBD development in a murine model of colitis.
Hence, in this study, we modified the standard chow diet of C57BL/6 mice (at 200 parts per
million-ppm iron) to half of the standard levels (100 ppm), or to double that of standard
(400 ppm) of iron and subsequently induced colitis using dextran sulfate sodium (DSS). Clini-
copathological outcomes were analyzed in parallel with the characterisation of the composition
of the gut microbial community by sequencing the 16S prokaryotic ribosomal subunit.
Materials and methods
Animals
Female C57BL/6 mice (n = 130), aged 8–9 weeks old, were purchased from Charles River Lab-
oratories (Margate, UK). Mice were fed a standard rodent chow pellet diet, during an initial
acclimatisation period of at least one week, with access to water ad libitum. All mice were indi-
vidually-caged in a specific pathogen-free animal facility with controlled temperature, humid-
ity and a pre-set dark-light cycle (12 h: 12 h). Eight groups were studied initially; two control
groups and six DSS-treated groups were maintained either for 8 days or up to 10 days. Three
additional control groups of mice (to compare the effects of diets alone) received drinking
water without DSS, but with varying amounts of dietary iron for a total of 10 days, under con-
ditions as described above (see Table 1). For each set of experiments, mice were matched for
age and body weight. The work described was conducted in accordance with UK Home Office
regulations under the Animals (Scientific Procedures) Act 1986 (ASPA). The University of
Liverpool Ethical Review Body also approved protocols. Study animals were observed for signs
of illness and/or welfare impairment and were euthanised by cervical dislocation.
Diets
The standard 10 mm compression pellet chow diet utilised contained 200 ppm iron (Rat and
Mouse Breeder and Grower Pelleted CRM (P)—Special Diets Services, Witham, Essex, UK).
Two modifications of this diet were used. The first diet was formulated to contain half the
amount of iron found in standard chow, ie. 100 ppm, a dietary level selected to reduce luminal
bacterial exposure to iron without being harmful to the mice. The second formulation con-
tained double the amount of iron found in standard chow, i.e. 400 ppm, a diet to increase bac-
terial exposure to iron without being overtly toxic to mice.
Induction of acute colitis using dextran sulfate sodium (DSS)
Mice were given 2% w/v dextran sodium sulfate (M.W. 36,000–50,000Da; Catalogue number:
160110; Lot number: 6683K; MP Biomedicals, UK) in their drinking water for 5 days to induce
colitis (~150 mL/mouse over 5 days), followed by another 5 days of DSS-free drinking water.
Mice were euthanised on day-8 or day-10.
Table 1. Experimental animal groups’ classification.
Iron (ppm) 100ppm 200ppm 400ppm 100ppm 200ppm 400ppm
DSS (2% w/v) - - - + + +
Number of mice (day-10) 6 20 6 14 14 14
Number of mice (day-8) - 8 - 16 16 16
https://doi.org/10.1371/journal.pone.0202460.t001
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Histopathological scoring of colonic inflammation
The distal colon was removed, fixed in 4% neutral buffered formalin, dehydrated, paraffin
wax-embedded and then 4 μm sections were cut by microtomy. The sections were stained with
hematoxylin and eosin (H&E), and inflammation scored, using the system described by Bauer
et al. [24].
Measurement of faecal calprotectin as a marker of the degree of intestinal
inflammation
Faecal pellets were collected from each cage (1 mice per cage), in all groups, on day 1, 8 and 10.
Faecal calprotectin levels were measured using an S100A8/S100A9 ELISA kit (Immundiagnos-
tik AG, Bensheim; Germany) as per the manufacturer instructions.
Assessment of faecal iron
The faecal iron (Fe2+ and Fe3+) concentration was measured using an iron immunoassay kit
[MAK025, Sigma-Aldrich]. This was performed using faecal pellets taken at the same time as
those for the faecal calprotectin ELISA.
High-throughput sequence analysis of bacterial communities from faecal
samples
Faeces (2 g) was sampled from each animal and bacterial DNA extracted using the Stratec PSP
Spin Stool DNA Plus Kit (STRATEC Molecular GmbH, Berlin; Germany) following the manu-
facturer recommended protocol. Isolated DNA was sent to the Centre for Genomic Research
at the University of Liverpool to generate the 16S Metagenomic Sequencing Library. Primers
described by Caporaso et al. [25] were used to amplify the V4 region of 16S rRNA; F: 5'ACAC
TCTTTCCCTACACGACGCTCTTCCGATCTNNNNNGTGCCAGCMGCCGCGGT AA3' and R:
5'GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGACTACHVGGGT WTCTAAT3'.
Approximately 5 μL of extracted DNA was used for first round PCR with conditions of 20
sec at 95˚C, 15 secs at 65˚C, 30 sec at 70˚C for 10 cycles then a 5 min final extension at 72˚C.
Amplicons were purified with Axygen SPRI Beads before a second-round PCR was performed
to incorporate Illumina sequencing adapter sequences containing indexes (i5 and i7) for sam-
ple identification as described in [25]. Fifteen cycles of DNA amplification by PCR were per-
formed using the same conditions as above, i.e., 25 cycles overall. Again, samples were purified
using Axygen SPRI Beads before being quantified using Qubit and assessed using the Frag-
ment Analyser. Successfully generated amplicon libraries were used for sequencing.
The final libraries were pooled in equimolar amounts using the Qubit and Fragment Analy-
ser, data and size-selected on the Pippin Prep using a size range of 350–550 base pairs (bp).
The quantity and quality of each pool were assessed by Bioanalyzer, and subsequently by
qPCR using the Illumina Library Quantification Kit from Kapa on a Roche Light Cycler
LC480II system according to the manufacturer instructions. The pool of libraries was
sequenced on one lane of the MiSeq at 2 x 250 bp paired-end sequencing [26]. To help balance
the complexity of the amplicon library, 15% PhiX was spiked as described by Altschul et al.
[27].
Bioinformatics analysis
Initial processing and quality assessment of the sequence data was performed using an in-
house pipeline. Base calling and de-multiplexing of indexed reads were conducted by
CASAVA version 1.8.2 (Illumina) as described by Schubert et al. [28]. The raw fastq files were
Altering dietary iron exacerbates colitis and dysbiosis
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trimmed to remove Illumina adapter sequences with any reads matching the adapter sequence
over at least 3 bp being trimmed off. The reads were further trimmed to remove low-quality
bases (reads <10 bp were removed). Read pairs were aligned to produce a single sequence for
each read pair that would entirely span the amplicon. Sequences with lengths outside of the
expected range (which are likely to represent errors) were also excluded. Sequences passing the
above filters for each sample were pooled into a single file. A metadata file was created to
describe each sample. These two files were used for metagenomics analysis using Qiime, ver-
sion 1.8.0 as described by Caporaso et al. [29]. Similar sequences were clustered into groups, to
define OTUs of 97% similarity. OTU-picking was performed using USEARCH7 as described
by Edgar et al. [30] to cluster sequences, remove chimeras, and define OTU abundance. The
Greengenes database of ribosomal RNA sequences, version 12.8 as described by McDonald
et al. [31], was used as a reference for reference-based chimera detection. To reduce the effect
of sample size and to estimate species richness within each sample (alpha diversity), OTU
tables were repeatedly sub-sampled (rarefied). For each rarefied OTU table, three measures of
alpha diversity were estimated: Chao1, the observed number of species, and the phylogenetic
distance. To allow inter-sample comparisons (beta-diversity), all datasets were sub-sampled
(rarefied). Rarefied OTU tables were used to calculate weighted and unweighted pair-wise
UniFrac matrices. UniFrac matrices were then used to generate UPGMA (Unweighted Pair-
Group Method with Arithmetic mean) trees and 2D principal component analysis (PCA)
plots.
Statistics
Normally distributed physiological and biochemical data (as determined by Shapiro-Wilks
test) were assessed by one-way analysis of variance followed by multiple pairwise comparisons
of treatment means using Dunnett’s test. Non-normally distributed data were assessed by
Kruskal-Wallis non-parametric-test followed by multiple pairwise comparisons (Conover-
Inman) test (Stats Direct version 3.0.171; Altrincham, UK).
For the bioinformatic analysis of microbiota data, Welch’s t-test was used with the false dis-
covery rate (FDR) Storey’s multiple correction tests. The q-value is the adjusted p-value based
on FDR calculation, where statistical significance was declared at p<0.05.
Results
Reduced dietary iron intake is associated with increased weight loss and
more severe colitis following the induction of DSS colitis
All mice treated with 2% w/v DSS lost body weight from day-5, with maximal weight loss
occurring on day-8. Mice ingesting a diet containing 100 ppm iron lost significantly more
weight (13 ± 1.53%) than seen with the other DSS treatment groups (i.e. 8.3 ± 1.09% for mice
ingesting 200 ppm iron, and 8.6 ± 1.33% for mice on 400 ppm iron); see Fig 1. Control mice,
ingesting dietary iron at 100 ppm, 200 ppm and 400 ppm, receiving no DSS treatment, showed
expected steady increases in body weight over the 10-day study period. No evidence of colitis
was observed in all untreated (controls) mice. In contrast, all mice treated with 2% w/v DSS
developed bloody diarrhoea within the last 5 days of the 10-day study. Histopathological exam-
ination established the presence of DSS-induced colitis, which was localised mainly to the dis-
tal part of the colon. Histological features of colitis observed included areas of mucosal loss,
inflammatory cell infiltration and oedema (Fig 2). Histological colonic inflammation severity
scores were significantly greater in mice consuming 100 ppm dietary iron and treated with 2%
Altering dietary iron exacerbates colitis and dysbiosis
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w/v DSS, compared with those mice receiving 2% w/v DSS and ingesting a diet containing
200 ppm or 400 ppm iron, at both day-8 and day-10 (Fig 3).
Faecal calprotectin concentration in DSS-treated mice during the 10-day
course
Faecal calprotectin concentrations were measured in faecal pellets collected from the cage of
each mouse in all groups at day-1, day-8, and day-10. Analysis of day-1 samples showed similar
levels (10.3 ‘mean’) in all groups indicating no treatment effects were yet apparent. Faecal
Fig 1. Daily weight changes. Percentage weight change in mice consuming diets containing iron [100 ppm (blue), 200 ppm (red) and
400 ppm (green)] during dextran sulfate sodium (DSS)-induced colitis, and mice consuming a diet containing 200 ppm iron without
DSS treatment (orange) during the 10-day study period. Data are presented as a mean ± standard error of the mean (SEM). Statistical
differences were assessed by Kruskal–Wallis test followed by multiple comparisons (Conover-Inman) tests (� p<0.05, �� p<0.01, ���
p<0.001, ���� p<0.0001). (n = 30 female mice per DSS-treated; n = 22 mice per untreated group).
https://doi.org/10.1371/journal.pone.0202460.g001
Fig 2. H & E histology. Representative Haematoxylin- and eosin-stained sections of the distal colon from untreated
and 2% w/v DSS-treated mice. Mice received either water (control, I) or 2% w/v DSS for 5 days followed by another 3
days on plain drinking water (II, III and IV) or 5 days on plain drinking water (V, VI, and VII). Arrowheads highlight
submucosal oedema; arrows highlight almost complete loss of colonic epithelium.
https://doi.org/10.1371/journal.pone.0202460.g002
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calprotectin concentration data were normalised to the values found in control samples with
higher levels seen in the mice on modified (half and double of the standard content) iron diet
compared to those fed the standard 200 ppm iron diet (Fig 4). This finding was seen at both
Fig 3. Inflammation score. Inflammation (colitis) scores for all groups of DSS-treated mice (n = 16 [8-days] and
n = 14 [10-days] mice per group) and untreated control mice (n = 24) on diets containing different levels of iron (100,
200 and 400 ppm). Horizontal lines represent medians. Significant differences were assessed using one-way ANOVA
followed by multiple comparisons against untreated control by Dunnett’s test; � p<0.05, �� p<0.01, ���� p<0.0001.
https://doi.org/10.1371/journal.pone.0202460.g003
Fig 4. Faecal calprotectin concentrations. Faecal calprotectin concentrations at three different time points (day-1, 8
and 10) for four groups, three DSS-treated groups (consuming diets containing 100, 200 and 400 ppm iron) and one
untreated control group (consuming a standard 200-ppm iron containing chow diet). Data are presented as a
mean ± SEM. Significant differences were identified using the Kruskal–Wallis test followed by multiple comparisons
(Conover-Inman) test; � p<0.05, ��� p<0.001. (30 samples for all DSS-treated groups and 22 samples for untreated
mice at each time point).
https://doi.org/10.1371/journal.pone.0202460.g004
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day-8 and day-10 although the most striking levels were recorded at day-8 (60 ± 1.11%,
40 ± 1.12% and 80 ± 1.08% increase for the half of the standard, standard and the double of the
standard iron diets, respectively). The maximal faecal calprotectin levels were seen at day-8
and correlated with the highest histological scores in DSS-treated mice that received 200 ppm
and 400 ppm iron containing diets compared to their corresponding day-10 non-DSS controls
(p<0.001).
Faecal iron concentrations in DSS-treated mice
Faecal iron concentrations were measured to investigate the net impact of dietary iron and
bleeding resulting from inflammation. Faecal pellets, from each mouse, were assessed for faecal
iron concentration (ferric and ferrous) from any (dietary and bleeding) source at the different
time points (day-1, 8 and 10). Data points from experimental groups were normalised to the
values found in the control samples (Fig 5). Faecal iron concentrations were increased, at day-
10, for all mice with DSS-induced colitis, compared to control mice, with the greatest level of
change being observed in mice receiving half of standard chow dietary iron levels, i.e. 100 ppm
(Fig 5). DSS-treated mice receiving the standard levels of iron (200-ppm diet) had significance
(P<0.05) faecal iron concentrations at day-8 vs day-8 within the control group of mice.
Observed differences in faecal iron concentrations between mice on half of standard chow die-
tary iron levels (100 ppm) and double the standard iron diet levels (400 ppm) were not statisti-
cally significant. This suggests that colitis and bleeding likely had more pronounced effects on
the faecal iron concentration than the amount of iron consumed in the diet alone.
Effect of iron on the microbiota composition in the colon after DSS-
induced colitis
To determine the effect of DSS and oral iron on the gut microbiota, fresh faecal samples were
compared at baseline and the end of each experiment (after 10 days from the start). After
Fig 5. Faecal iron concentrations. Faecal iron concentration at three different time points (day-1, 8 and 10) for four
groups, three DSS-treated groups (consuming diets containing 100, 200 and 400 ppm iron) and one untreated control
group (consuming a standard 200-ppm iron containing chow diet). Data are presented as a mean ± SEM. Significant
differences were identified using the Kruskal–Wallis test followed by multiple comparisons (Conover-Inman) test; �
p<0.05.
https://doi.org/10.1371/journal.pone.0202460.g005
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sequence processing and filtering, a total of 11,811,301 chimera-checked 16S rRNA sequences
(166,356 ± 59,353 per sample) spanning a total of 204,331 OTUs were obtained.
Analysis of alpha-diversity (statistical significance of Shannon) indicated that there was a
significant reduction in species richness in faecal samples taken from the 400 ppm iron fed, the
DSS-treated group between day-1 and day-10 (P<0.0066; Shannon diversity index) (Fig 6A).
To assess whether the differences in species richness were attributable to alterations in the rela-
tive abundance of specific bacterial groups, we compared the proportions of various
Fig 6. Relative abundance of bacteria. Effect of iron on the microbiota composition in the colon after DSS-induced
colitis. (a) Shannon effective diversity boxplots display decreased numbers of dominant molecular species in all groups,
day-1 versus day-10 of the study. (b) The Phylum-level taxonomic composition of all samples (average relative
abundance). Ctr. = untreated controls on a standard chow diet containing 200 ppm iron; DSS = 2% w/v dextran sulfate
sodium (DSS) treated mice on diets containing low iron (100 ppm), standard iron (200 ppm) and high iron (400 ppm)
levels.
https://doi.org/10.1371/journal.pone.0202460.g006
Altering dietary iron exacerbates colitis and dysbiosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0202460 October 11, 2018 9 / 18
taxonomic groups at the phylum level. Bacteroidetes was the most abundant phyla present, fol-
lowed by Firmicutes, Cyanobacteria and Proteobacteria (Table 2). Phyla changes were seen in
all DSS-treated groups when day-10 samples were compared to day-1. However, these changes
were only observed to be statistically significant for the mice consuming 400 ppm iron, with
increases observed in the numbers of Proteobacteria (increased 1.40 ± 0.1-fold) and Actinobac-
teria (1.30 ± 0.1-fold increase) and concomitant reductions in Firmicutes (0.6 ± 0.1-fold) and
Bacteroidetes (0.8 ± 0.04-fold); these changes have been explicitly accredited to Proteobacteria,
Actinobacteria, Firmicutes and Bacteroidetes, which occurred in the presence of inflamed ver-
sus non-inflamed tissues even within the same group. Therefore, the double of the standard
iron diet group had the highest relative abundance among inflamed (colitis) groups on the
subject of reduction or increase changes (day-1 vs day-10) (Table 2 and Fig 6B).
We searched for differences between day-1 and day-10 samples by considering delta-values
calculated as differences in sequence abundances (before and after treatment). No, statistically
significant changes were observed in mice receiving diets containing half of the standard iron
levels where DSS was administered, despite showing similar trends to those mice on double
the standard diet iron levels (Fig 7).
Principal Component Analysis (PCA) was used to identify linear combinations of gut
microbial taxa that were associated with specific diets. There was a clear separation of samples
from the mice consuming a chow diet containing 400 ppm before (day-1) and after (day-10)
DSS-treatment which was not seen in the other treatment groups (Fig 8). This suggests that
DSS-induced colitis, in the presence of double the standard level of dietary iron intake, affected
the bacterial community significantly more than that observed in all other diet groups
(P<0.0066; Shannon diversity index) (Fig 6A).
Discussion
In this study, we used a murine model of IBD in which 2% w/v DSS was administered to mice
and investigated the impact of changing dietary iron intake on the degree of inflammation and
the bacterial components of the intestinal microbiome.
Alteration of iron content from standard chow diet levels (200 ppm) significantly influ-
enced the severity of colitis induced by DSS in mice. Clinically, for mice treated with DSS,
those fed half the standard iron levels developed more severe colitis (compared to those con-
suming chow diets with iron levels at 200 ppm, or at higher levels of 400 ppm. DSS-treated
mice that received 100 ppm dietary iron significantly also lost more body weight than observed
in the other treatment groups. However, at molecular level increasing dietary iron 2-fold
above standard levels, to 400 ppm, led to worse inflammation and greater faecal calprotectin
concentrations at day-8, than was found in mice consuming a 100 ppm iron diet. Our observa-
tion agrees with the findings of an earlier study performed by Carrier and colleagues [32] in
Table 2. Comparison between all groups regarding proportions of bacteria at the phylum level at day-1 vs day-10.
Taxonomy Control
Day-1
Control
Day-10
100ppm DSS
Day-1
100ppm DSS
Day-10
200ppm DSS
Day-1
200ppm DSS
Day-10
400ppm DSS
Day-1
400ppm DSS Day-10
Actinobacteria 6.63% 7.25% 6.77% 8.48% 7% 9.28% 7.35% 9.82%
Bacteroidetes 27.03% 24.98% 30.38% 30.73% 32% 31.33% 34.62% 27.27%
Cyanobacteria 19.13% 22.02% 19.80% 25.67% 20% 27.87% 20.70% 30.23%
Firmicutes 26.98% 24.15% 21.33% 6.20% 20% 10.2% 15.57% 6.22%
Proteobacteria 13.22% 15.17% 13.85% 17.55% 15% 19.65% 14.82% 20.58%
TM7 1.63% 1.63% 1.65% 2.02% 2% 2.27% 1.80% 2.48%
Tenericutes 2.42% 1.90% 3.55% 0.45% 1% 0.15% 2.53% 0.07%
https://doi.org/10.1371/journal.pone.0202460.t002
Altering dietary iron exacerbates colitis and dysbiosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0202460 October 11, 2018 10 / 18
DSS-treated rats which emphasised the role of nutrient iron in modulating inflammation. Spe-
cifically, the severity of colitis appeared to positively associate with the amount of iron con-
sumed. However, they did not investigate the effects of consumption of lower than normal
amounts of iron in their work [32]. A study by Erichsen et al. [33] reported that the addition of
low-dose oral ferrous fumarate (0.60 mg Fe/kg/d) to Wistar rats to levels present in standard
chow 130 mg/kg (ferrous carbonate, 40 mg/kg; the remainder representing organic iron), also
increased the severity of DSS-induced colitis. In the same study, oral supplementation with
higher doses of ferrous fumarate caused a further increase in histological intestinal inflamma-
tion [33]. Our study shows that a diet depleted in iron (100 ppm) can also exacerbate colitis
severity. The mice that consumed a diet containing 100 ppm iron, and treated with 2% w/v
Fig 7. Proportions of sequences. Box plot is showing the distribution in the proportion of four key phyla (Firmicutes,
Bacteroidetes, Actinobacteria and Proteobacteria) assigned to samples from all groups at day-1 and day-10. Boxes
indicate the interquartile ranges (75th to 25th IQR) of the data. The median values are shown as lines within the box,
and the mean values are indicated by stars. Whiskers extend to the most extreme value within 1.5�IQR. Outliers are
shown as crosses. Statistical differences were assessed by Welch’s t-test followed by Storey’s FDR multiple test
correction.
https://doi.org/10.1371/journal.pone.0202460.g007
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DSS, showed greater increased intestinal inflammation than mice ingesting a standard chow
diet containing 200ppm iron, and treatment with 2% w/v DSS.
It has previously been suggested that iron formulations can be beneficial (ferrous bisglyci-
nate) or highly damaging (ferric ethylenediaminetetraacetic acid (FEDTA)) during DSS-
induced colitis experiments [9]. Iron supplementation at different doses also induced shifts in
the gut microbial community and inferred metabolic pathways [9]. Our findings indicate that
any significant alteration in standard dietary iron (above or below the standard chow levels of
200 ppm) may have a negative impact on the severity of DSS-induced colitis in mice.
For humans, faecal calprotectin measurement is commonly used as an assessment tool for
disease activity in IBD [34, 35]. We, therefore, used this additional approach and measured
Fig 8. Principal Coordinate/Component analysis. Analysis of faecal microbiota shifts assessed by Principal
Coordinate/Component Analysis (PCA-PCoA) plots of the unweighted UniFrac distances of pre-and post-DSS-
intervention stool samples (I) PCoA; all groups (II) PCA; DSS-treated mice on diets containing low iron (100 ppm),
standard iron (200 ppm) and high iron (400 ppm) (b, c, and d respectively) and untreated control mice on a diet
containing standard 200 ppm iron (a) at phylum-level, phylogenetic classification of 16S rRNA gene sequences.
Symbols represent data from individual mice, colour-coded by the indicated metadata. Statistical differences were
assessed by Welch’s t-test followed by Storey’s FDR multiple test correction.
https://doi.org/10.1371/journal.pone.0202460.g008
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murine faecal calprotectin levels to examine whether dietary iron levels affected inflammation.
The degree of colonic inflammation was found to be significantly higher for DSS-treated mice
receiving 400 ppm iron in their chow as assessed by faecal calprotectin concentration. The his-
topathological changes observed were consistent with the faecal calprotectin levels measured,
which were higher at day-8 than at day-10, particularly in the high- and low-iron fed, DSS-
treated groups. A previous study in African infants by Jaeggi and colleagues [36] also noted
that oral iron supplementation was associated with increased concentrations of faecal calpro-
tectin and with an increased rate of diarrhoea [36]. In contrast, a mouse study by Kortman
et al.[37] showed that faecal calprotectin concentrations were not influenced by dietary iron
intervention alone, but only following an enteric infection (Citrobacter rodentium), with faecal
calprotectin concentrations being significantly lower in mice consuming an iron-deficient
diet. Kortman et al. [37] also found that Gram-positive Enterorhabdus appeared only after
enteric infection and its relative abundance, and faecal calprotectin concentrations observed,
were highest in a standard (45 mg/kg) dietary iron group [37].
In the present study, all DSS-treated mice showed an increase in faecal calprotectin levels at
day-8; this was most prominent in the mice consuming 400 ppm dietary iron. However, all
DSS-treated groups showed greater levels of calprotectin in their stool at day-8 vs day-10. This
further supports the view that altering the standard levels of dietary iron may exacerbate the
severity of murine DSS-induced colitis.
One key source of iron accessible to the intestinal microbiota is unabsorbed, excess dietary
iron and any significant changes in luminal iron concentrations may have a potential impact
on structure, function and diversity of the intestinal microbiome [36, 38]. Iron replacement
therapy is a common treatment in patients with anaemia and IBD, such as in Crohn’s disease,
although such supplements may also influence intestinal inflammation as well as intestinal
microbial community structure and function [32, 39].
Measuring faecal iron concentrations would help to assess the severity of bleeding during
colitis. However, it is difficult to distinguish between the iron that comes from the diet and
that which has been released from red blood cells because of luminal bleeding during colitis.
Following a collection of faecal pellets at different time points from each mouse and calculating
the iron content (ferric and ferrous) (dietary and bleeding source) and comparing results
observed between groups at day-10, the absolute amount of faecal iron appeared to be different
for DSS-treated groups (3.3 -fold increase in half of the standard iron group, and 2.3-fold
increase in the double the standard iron group compared with the control group at day-10).
There was a significant increase in faecal iron at day-8, in standard iron diet group, but not in
the other groups. As there was as if an to increased (no significance) in faecal iron in mice fed
100 ppm iron compared with those mice fed the standard chow diet level of 200 ppm, this sug-
gests that luminal bleeding may be a contributing factor to faecal iron quantitation in the DSS-
induced colitis model.
Overall in this study, changes (increase or decrease) in the iron content of the diet from
standard chow levels (200 ppm) appeared to significantly enhance colonic inflammation in a
DSS-induced mouse model of IBD. There appeared to be synergy between dietary iron levels
and DSS treatment of colonic inflammation and faecal calprotectin levels. Faecal iron concen-
trations are known to be increased by inflammation, as well as oral iron intake [36]. This may
explain the paradox in the half standard dietary iron fed group where luminal bleeding during
colitis caused an increase in the faecal iron concentration despite lower levels of iron being
consumed in the diet.
Changes in the microbiota are thought to be a major contributory factor in many human
diseases, including IBD [40, 41]. The most distinct phylum level alterations in IBD are a reduc-
tion in the abundance of Bacteroidetes and Firmicutes and increased proportions of
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Proteobacteria, in particular, increased numbers of bacteria from the family Enterobacteriaceae
[14, 40, 42, 43]. Murine models of IBD provide a means to investigate bacteria in IBD [22],
and dysbiosis of the intestinal microbiota has been shown to induce murine colitis [23, 44].
Here, we analysed inter- and intra-group differences and similarities between the intestinal
microbiota composition of 24 laboratory C57BL/6 mice (6 mice/group). Qualitative and quan-
titative-based analysis of the faecal gut microbiota at two different time points (day-1 and 10)
for DSS-treated groups (100, 200 and 400 ppm dietary iron) and untreated mice (controls) was
undertaken. Principal component analysis indicated an overlap of all microbial profiles, except
for the double standard dietary iron (400 ppm) fed DSS-treated mice. Based on the PCA,
ingestion of double the standard level of dietary iron was found to be the most important fac-
tor responsible for clustering.
Some studies have shown that subsets of CD and UC intestinal tissue and faecal samples
have an abnormal gut microbiota, characterised by depletion of commensal bacteria, in partic-
ular members of the phyla Firmicutes and Bacteroidetes, and an increase in Proteobacteria [14,
43]. Doubling the standard level of iron in the chow diet (i.e. to 400ppm) here led to significant
alterations in microbiota composition in 2% w/v DSS-treated mice, with our study showing a
similar pattern of change to those observed in human IBD, including increases in Proteobac-
teria and concomitant decreases in Firmicutes and Bacteroidetes. Similar trends were found in
the other DSS-treated groups of mice, but these changes in microbiota composition did not
reach statistical significance. An increase in the iron content of the diet changed the micro-
biota after colitis was induced with DSS, which was not observed in the standard or lower die-
tary iron groups. A shifting balance within the intestinal microbiota could alter host immune
response and open niches for the establishment of key environmental-shaping bacteria in the
intestine, for example, the significant decrease in numbers of beneficial Firmicutes could create
an opportunity for, and encourage the growth of potential gut pathogens [45].
Proteobacteria and Actinobacteria were increased in all mice with colitis, especially those
consuming the high iron diet (400ppm iron): this suggests that the colitis drives a change in
the microbiome, and it is exacerbated by iron supplementation. In contrast, when colitis was
induced in mice taking a low iron diet (100ppm iron) Bacteroidetes modestly increased in
abundance, but this decreased in mice taking the high iron diet: this suggests that growth of
Bacteroidetes is influenced by iron. As mice taking a low iron diet had worse colitis than those
taking standard chow (200ppm iron), the data imply that Bacteroidetes might contribute to the
severity of colitis. More work is needed: for example, what is the impact of a low iron diet on
the microbiome in the absence of colitis?
Bacteria species within the Firmicutes phylum are predominant in the generation of short-
chain fatty acids, particularly butyrate, from dietary metabolism of insoluble fibre, resistant
starches and fermentable soluble fibres (non-starch polysaccharides), [46], thereby providing a
key anti-inflammatory effectors to ameliorate animal models of colitis [47].
This is the first study to use models of colitis to contemporaneously assess the influence of
dietary iron content on both disease activity and the microbiome. It emphasises the detrimen-
tal effects of both halving and doubling the amount of iron in the diet on a murine model of
IBD. The diet with double the standard level of iron (400 ppm) led to key changes in the
microbiome and this would imply that these changes observed were not simply driven by the
severity of inflammation, but rather that lumenal free iron can also contribute to the complex
interaction of factors that lead to the development of a dysbiotic state as has frequently been
observed in IBD. There is more to understand how all sources of luminal iron influence IBD.
Furthermore, work is needed to outline the physiological impact on the gut microbiota resul-
tant from increased availability of luminal iron and how this may affect bacterial phyla and
diversity. Future intervention studies in humans will be invaluable to further define the
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complex effects of different doses of therapeutic oral iron on the human gut microbiota, partic-
ularly to understand the metabolic consequences of observed phyla changes.
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